Explore the molecular mechanisms of androgen control in prostate cancer, from basic signaling to cutting-edge therapies targeting treatment resistance.
Exploring how endosomal recycling inhibitors downregulate the androgen receptor and synergize with enzalutamide in prostate cancer treatment.
Exploring the relationship between androgen receptors and tumor-infiltrating lymphocytes across breast cancer subtypes and their clinical implications.
Explore how Proxalutamide (GT0918), a potent androgen receptor pathway inhibitor, is transforming treatment for prostate cancer and COVID-19 through its dual mechanism of action.